Correction to: Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines (NeuroMolecular Medicine, (2022), 24, 2, (113-124), 10.1007/s12017-021-08667-x)

Hong Chieh Tsai; Kuo Chen Wei; Pin-Yuan Chen; Chiung Yin Huang; Ko Ting Chen; Ya-Jui Lin; Hsiao Wei Cheng; Chun Hao Huang; Hsiang Tsui Wang

doi:10.1007/s12017-021-08680-0

Correction to: Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines (NeuroMolecular Medicine, (2022), 24, 2, (113-124), 10.1007/s12017-021-08667-x)

Hong Chieh Tsai, Kuo Chen Wei, Pin-Yuan Chen, Chiung Yin Huang, Ko Ting Chen, Ya-Jui Lin, Hsiao Wei Cheng, Chun Hao Huang, Hsiang Tsui Wang^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	232
Number of pages	1
Journal	NeuroMolecular Medicine
Volume	24
Issue number	2
DOIs	https://doi.org/10.1007/s12017-021-08680-0
State	Published - 06 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s12017-021-08680-0

Cite this

Tsai, H. C., Wei, K. C., Chen, P.-Y., Huang, C. Y., Chen, K. T., Lin, Y.-J., Cheng, H. W., Huang, C. H., & Wang, H. T. (2022). Correction to: Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines (NeuroMolecular Medicine, (2022), 24, 2, (113-124), 10.1007/s12017-021-08667-x). NeuroMolecular Medicine, 24(2), 232. https://doi.org/10.1007/s12017-021-08680-0

@article{ad24aeba37de4bcab6de36def26db7ef,

title = "Correction to: Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines (NeuroMolecular Medicine, (2022), 24, 2, (113-124), 10.1007/s12017-021-08667-x)",

author = "Tsai, {Hong Chieh} and Wei, {Kuo Chen} and Pin-Yuan Chen and Huang, {Chiung Yin} and Chen, {Ko Ting} and Ya-Jui Lin and Cheng, {Hsiao Wei} and Huang, {Chun Hao} and Wang, {Hsiang Tsui}",

year = "2022",

month = jun,

doi = "10.1007/s12017-021-08680-0",

language = "英语",

volume = "24",

pages = "232",

journal = "NeuroMolecular Medicine",

issn = "1535-1084",

publisher = "Springer",

number = "2",

}

Tsai, HC, Wei, KC, Chen, P-Y, Huang, CY, Chen, KT , Lin, Y-J, Cheng, HW, Huang, CH & Wang, HT 2022, 'Correction to: Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines (NeuroMolecular Medicine, (2022), 24, 2, (113-124), 10.1007/s12017-021-08667-x)', NeuroMolecular Medicine, vol. 24, no. 2, pp. 232. https://doi.org/10.1007/s12017-021-08680-0

Correction to: Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines (NeuroMolecular Medicine, (2022), 24, 2, (113-124), 10.1007/s12017-021-08667-x). / Tsai, Hong Chieh; Wei, Kuo Chen; Chen, Pin-Yuan et al.
In: NeuroMolecular Medicine, Vol. 24, No. 2, 06.2022, p. 232.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines (NeuroMolecular Medicine, (2022), 24, 2, (113-124), 10.1007/s12017-021-08667-x)

AU - Tsai, Hong Chieh

AU - Wei, Kuo Chen

AU - Chen, Pin-Yuan

AU - Huang, Chiung Yin

AU - Chen, Ko Ting

AU - Lin, Ya-Jui

AU - Cheng, Hsiao Wei

AU - Huang, Chun Hao

AU - Wang, Hsiang Tsui

PY - 2022/6

Y1 - 2022/6

UR - http://www.scopus.com/inward/record.url?scp=85112644154&partnerID=8YFLogxK

U2 - 10.1007/s12017-021-08680-0

DO - 10.1007/s12017-021-08680-0

M3 - 评论/辩论

C2 - 34357568

AN - SCOPUS:85112644154

SN - 1535-1084

VL - 24

SP - 232

JO - NeuroMolecular Medicine

JF - NeuroMolecular Medicine

IS - 2

ER -

Correction to: Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines (NeuroMolecular Medicine, (2022), 24, 2, (113-124), 10.1007/s12017-021-08667-x)

UN SDGs

Access to Document

Other files and links

Cite this